Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Q1 financials are not bad !
Hello everyone
I’ve been away from this board for some time now and i lost track of new developments regarding amarin
Would somebody let me know if there is any new development on the legal front?
Thxxx
Ex77
Why is it only for >500mg/dl???
EddingPharm (EDDING), has received regulatory approval for VASCEPA® (icosapent ethyl) from China’s National Medical Products Administration (NMPA). NMPA granted approval for VASCEPA as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia (≥500 mg/dL).
Sleven
Is the embargo a positive sign ?
Odysseas Kostas, M.D.
Dr. Kostas joined the board of directors of Armata Pharmaceuticals in February 2020. At Innoviva, Inc. (NASDAQ: INVA), a company with a portfolio of royalties that include respiratory assets partnered with Glaxo Group Limited, Dr. Kostas has served as a member of the Board of Directors since December 2017 and as Chairman of the Board of Directors since April 2018. He is currently a member of Innoviva’s Audit Committee and Nominating/Corporate Governance Committee. Dr. Kostas is a Partner and Senior Analyst at Sarissa Capital Management LP focused on improving the strategies of companies to enhance shareholder value. Prior to joining Sarissa Capital, Dr. Kostas served as a Director at Evercore ISI (formerly ISI), covering the biotechnology and pharmaceutical industries. Previously, he practiced internal medicine as part of the Yale New Haven Health System and was engaged as a consultant to various biotechnology companies. Dr. Kostas currently serves on the board of directors of Enzon Pharmaceuticals
Marjac when do you expect we might hear from the court of appeal ?
Many thanks as always
When is the hearing of the case ?
Congrats to all those who voted “BLUE”!
A quick question: what are the catalysts for the SP during 2023?
Thxx
I am happy !
What time is the meeting tomorrow ?
Today’s presentation must be good for whoever is against the current management !
Thank u PWO
Lizz
I won’t loose a second of my time on these losers !
DAR
Both parties are playing all their cards, that’s why i believe AD will have a TV appearance to blow-up all of amarin’s arguments and present his plan
Expect AD to be on CNBC & Bloomberg sometimes next week !
Given the war of letters between Sarissa and Amarin current management, there zero chance that AD will keep KM in his position after he takes control
I voted my shares short time ago !
Blue all the way
Marjac
Can Amarin use the terms of settlement with HealthNet in future negotiations with insurance companies, while keeping it confidential for the public ?
Thxx
From Amarin 8-K
On December 26, 2022, Amarin Corporation plc (the “Company”) entered into a Settlement Agreement (the “Settlement Agreement”) with Health Net, LLC that resolves previously disclosed patent infringement litigation in the U.S. District Court in Delaware. The specific terms of the settlement are confidential. The Company is pleased with the outcome and believes entering into the Settlement Agreement will provide significant value in the market with payors.
The Company will continue to vigorously defend its intellectual property rights related to VASCEPA.
What about litigation against healthnet ?
Thank you ??
When will we know the results of RESPECT ?
Thanks Lizzy
When is the general assembly date?
Ex77
Is what's going to happen today a result of discussion between Denner and Amarin management ?
Raf and Rose
Keep in mind last week was a short week
Captbeer !
Ur the master
Cost-effectiveness analysis from REDUCE-IT now out. Bottom line, icosapent ethyl is extremely cost-effective in high-risk patients with hypertriglyceridemia despite statins
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2789004?utm_source=twitter&utm_campaign=content-shareicons&utm_content=article_engagement&utm_medium=social&utm_term=021522#.Ygumf6oXkN8.twitter
Waaaw
40% chance of remanding to judge Du, is a decent chance
Thank you Marjac !
Let’s hope that Dyk has drained his energy in this case and will be silent in Marjac’s
When is the deadline for Amarin to file an updated infringement case against Hikma?
Marjac
In few words: you are truly a great fighter, wish you all the best not only for tomorrow but in every single challenge in your life
76,473
Marjac
Another 10 days to your oral arguments
I am counting the days
Fingers crossed
Amarin up 10% at Frankfurt stock exchange !
Let’s hope the US market follows
76,923